Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Name: Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
License: Public Domain

Emory University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced lung adenocarcinoma, refractory lung adenocarcinoma, stage iii lung cancer ajcc v8, stage iv lung cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 651259
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.